Tumors were processed shortly after completing the antibody infusion and analyzed by quantitative IHC for IBA1 and colocalized IBA1/CD206, as indicated in Fig. 1 (the results were again normalized to the tumor cross-sectional area and total cell density, Supplementary Fig. S2). The gene discussed is MRC1; the disease is neoplasm.